Evaluation of serum YKL-40 and cardiovascular risk in chronic kidney disease
El Senosy, F., Morsy, M., Mohamed, N., Albanna, A. (2018). Evaluation of serum YKL-40 and cardiovascular risk in chronic kidney disease. EKB Journal Management System, 2(2), 64-74. doi: 10.4103/sjamf.sjamf_13_18
Fatma M. El Senosy; Mona M. Morsy; Nagwa A. Mohamed; ALRomisa S. Albanna. "Evaluation of serum YKL-40 and cardiovascular risk in chronic kidney disease". EKB Journal Management System, 2, 2, 2018, 64-74. doi: 10.4103/sjamf.sjamf_13_18
El Senosy, F., Morsy, M., Mohamed, N., Albanna, A. (2018). 'Evaluation of serum YKL-40 and cardiovascular risk in chronic kidney disease', EKB Journal Management System, 2(2), pp. 64-74. doi: 10.4103/sjamf.sjamf_13_18
El Senosy, F., Morsy, M., Mohamed, N., Albanna, A. Evaluation of serum YKL-40 and cardiovascular risk in chronic kidney disease. EKB Journal Management System, 2018; 2(2): 64-74. doi: 10.4103/sjamf.sjamf_13_18